Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Rank	Δ	Cancer	Trial Gap Index (percentile points)	Percentile	Confidence	Sources	Why #n?
1	=	Malignant Colon Neoplasm	+51.9	100	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 20267 formula percentile(mortality_count) − percentile(active_trials) activity 225 burdenPercentile 88.9 activityPercentile 37 ranking row 2602333
2	=	Malignant Vulvar Neoplasm	+25.9	96.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1262 formula percentile(mortality_count) − percentile(active_trials) activity 54 burdenPercentile 33.3 activityPercentile 7.4 ranking row 2602334
3	=	Malignant Uterine Corpus Neoplasm	+14.8	92.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5962 formula percentile(mortality_count) − percentile(active_trials) activity 411 burdenPercentile 66.7 activityPercentile 51.9 ranking row 2602335
4	=	Cutaneous Melanoma	+14.8	88.9	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 2744 formula percentile(mortality_count) − percentile(active_trials) activity 78 burdenPercentile 37 activityPercentile 22.2 ranking row 2602336
5	=	Malignant Ovarian Neoplasm	+14.8	85.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 14193 formula percentile(mortality_count) − percentile(active_trials) activity 684 burdenPercentile 85.2 activityPercentile 70.4 ranking row 2602337
6	=	Malignant Bladder Neoplasm	+11.2	81.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4769 formula percentile(mortality_count) − percentile(active_trials) activity 346 burdenPercentile 55.6 activityPercentile 44.4 ranking row 2602338
7	=	Malignant Vaginal Neoplasm	+11.1	77.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 411 formula percentile(mortality_count) − percentile(active_trials) activity 31 burdenPercentile 11.1 activityPercentile 0 ranking row 2602339
8	=	Malignant Laryngeal Neoplasm	+11.1	74.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 748 formula percentile(mortality_count) − percentile(active_trials) activity 66 burdenPercentile 25.9 activityPercentile 14.8 ranking row 2602340
9	=	Malignant Pancreatic Neoplasm	+11.1	70.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 21092 formula percentile(mortality_count) − percentile(active_trials) activity 904 burdenPercentile 92.6 activityPercentile 81.5 ranking row 2602341
10	=	Malignant Rectal Neoplasm	+3.8	66.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4483 formula percentile(mortality_count) − percentile(active_trials) activity 386 burdenPercentile 51.9 activityPercentile 48.1 ranking row 2602342
11	=	Malignant Anal Neoplasm	+3.7	63	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 732 formula percentile(mortality_count) − percentile(active_trials) activity 68 burdenPercentile 22.2 activityPercentile 18.5 ranking row 2602343
12	=	Malignant Kidney Neoplasm	+3.7	59.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4923 formula percentile(mortality_count) − percentile(active_trials) activity 453 burdenPercentile 59.3 activityPercentile 55.6 ranking row 2602344
13	=	Malignant Breast Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 42000 formula percentile(mortality_count) − percentile(active_trials) activity 2627 burdenPercentile 96.3 activityPercentile 96.3 ranking row 2602345
13	=	Malignant Lung Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 67155 formula percentile(mortality_count) − percentile(active_trials) activity 2644 burdenPercentile 100 activityPercentile 100 ranking row 2602346
13	=	Malignant Thyroid Gland Neoplasm	0	55.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 1003 formula percentile(mortality_count) − percentile(active_trials) activity 176 burdenPercentile 29.6 activityPercentile 29.6 ranking row 2602347
16	=	Malignant Salivary Gland Neoplasm	-3.7	44.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 309 formula percentile(mortality_count) − percentile(active_trials) activity 63 burdenPercentile 7.4 activityPercentile 11.1 ranking row 2602348
17	=	Malignant Hypopharyngeal Neoplasm	-3.7	40.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 68 formula percentile(mortality_count) − percentile(active_trials) activity 53 burdenPercentile 0 activityPercentile 3.7 ranking row 2602349
18	=	Malignant Central Nervous System Neoplasm	-7.4	37	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 7415 formula percentile(mortality_count) − percentile(active_trials) activity 823 burdenPercentile 70.4 activityPercentile 77.8 ranking row 2602350
19	=	Malignant Mesothelioma	-7.4	33.3	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 627 formula percentile(mortality_count) − percentile(active_trials) activity 96 burdenPercentile 18.5 activityPercentile 25.9 ranking row 2602351
20	=	Leukemia	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 9909 formula percentile(mortality_count) − percentile(active_trials) activity 1769 burdenPercentile 81.5 activityPercentile 88.9 ranking row 2602352
20	=	Malignant Liver Neoplasm	-7.4	29.6	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8860 formula percentile(mortality_count) − percentile(active_trials) activity 906 burdenPercentile 77.8 activityPercentile 85.2 ranking row 2602353
22	=	Multiple Myeloma	-11.1	22.2	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 5470 formula percentile(mortality_count) − percentile(active_trials) activity 814 burdenPercentile 63 activityPercentile 74.1 ranking row 2602354
23	=	Malignant Cervical Neoplasm	-14.9	18.5	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4207 formula percentile(mortality_count) − percentile(active_trials) activity 505 burdenPercentile 44.4 activityPercentile 59.3 ranking row 2602355
24	=	Hodgkin Lymphoma	-18.5	14.8	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 440 formula percentile(mortality_count) − percentile(active_trials) activity 179 burdenPercentile 14.8 activityPercentile 33.3 ranking row 2602356
25	=	Non-Hodgkin Lymphoma	-18.5	11.1	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 8812 formula percentile(mortality_count) − percentile(active_trials) activity 2168 burdenPercentile 74.1 activityPercentile 92.6 ranking row 2602357
26	=	Malignant Gastric Neoplasm	-18.6	7.4	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 4478 formula percentile(mortality_count) − percentile(active_trials) activity 652 burdenPercentile 48.1 activityPercentile 66.7 ranking row 2602358
27	=	Malignant Esophageal Neoplasm	-22.3	3.7	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 3007 formula percentile(mortality_count) − percentile(active_trials) activity 518 burdenPercentile 40.7 activityPercentile 63 ranking row 2602359
28	=	Malignant Nasopharyngeal Neoplasm	-37	0	Medium confidence	cdc-uscs clinicaltrials cdc-wonder seer iarc-globocan	inputs deaths 208 formula percentile(mortality_count) − percentile(active_trials) activity 261 burdenPercentile 3.7 activityPercentile 40.7 ranking row 2602360

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 6530fc7f75733db32a7c0da9

Methodology

How this table was built

Formula: percentile(mortality_count) − percentile(active_trials)
Version: ci-trial-gap-v1
Scope: USA · Female · all ages · 2017 · top-level cancers
Scope key: geo=USA|sex=female|age=all|year=2017|level=top
Eligible entities: 28
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: 6530fc7f75733db32a7c0da9
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality clinicaltrials cdc-wonder seer iarc-globocan
Aggregation: none

Eligibility

requires: mortality_count
active_trials
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.